Sponsored by:
Convergent Evolution Towards Bioprocessing 4.0
The BioContinuum™ Platform is a convergent offering of advanced bioprocessing, software, automation and analytic technologies to achieve greater speed, flexibility and quality empowering biopharmaceutical manufacturers to confidently enter the era of next generation processing and Bioprocess 4.0.
Early adopters of the BioContinuum platform has seen considerable improvements in efficiency, productivity and ease of use.
BioContinuum’s digital platform has proven success in digitizing our customers’ entire bioprocessing workflow from start to finish.
Merck’s Bio4C ProcessPad™ software enabled our clients to comply with cGMP manufacturing and leverage their data.
Merck’s expertise and technologies has helped manufacturers navigate through next generation bioprocessing in facilities that produces life-saving mAbs. Customer feedbacks on their returns on investments has been positive, among many other benefits. Merck has empowered our clients to transform into paper-less manufacturing facilities. Our Bio4C is 21 CFR-compliant by industry standards.
Convergent Bioprocessing: An Evolutionary Journey Across Many Disciplines
The facility of the future will require a transformation in how biologics are developed and manufactured
